Wall Street opens the week with further declines in the technology sector. Nasdaq 100 futures are down about 1.2%, S&P 500 futures are down about 0.4%, and the Dow Jones is close to flat. The S&P 500 is on track for a third consecutive losing session. The gap between the indices shows this is not a selloff across the whole market. Investors are reducing exposure to AI and semiconductor stocks.
The biggest shadow hangs over Nvidia. The company has just had its worst week since April 2025, and tomorrow after the close it reports results for the third quarter of its fiscal year. It will be the first report since Jensen Huang stepped down as CEO and left the board (November 12), amid an investigation by the board of directors. CFO Colette Kress is leading the company on an interim basis. The market will not focus only on revenue (guidance is about $108 billion). It will also look at the new leadership, the strategy, and the impact of export restrictions on the most advanced chips going to China. There are also questions about whether the restrictions were circumvented in sales to Chinese companies. The market is also following reports of a possible return of Huang, which the Financial Times has covered among others. His allies reportedly set up a “war room,” and two major investors (Altimeter and Atreides) urged the board to consider all options. This adds uncertainty right before the report. A moment after the US market opened, Donald Trump said that Huang did not endanger US national security. The president has publicly defended the former CEO from the start. Nvidia’s board has also said it has no reason to believe that national security or company secrets were compromised. Such words may weaken the regulatory-risk angle and fuel speculation about Huang’s return, although the FBI investigation into the matter is still ongoing.
The second key event is Anthropic’s debut on the Nasdaq (ticker ANT). The IPO is due to be priced on Wednesday, and trading starts on Thursday. The range is $70-78 per share, which implies a valuation of up to about $1.4 trillion on a fully diluted basis. Interest is high, as orders have exceeded the offering about sixfold. With Nvidia weakened, the debut matters more. Dan Ives of Yorkville Ives sees it as a “big near-term win” for the whole sector that could restore confidence in the AI growth thesis. The market will also ask about the profitability of the business model, because this will be a test of the industry’s maturity.
Thursday will also bring the first meeting of Trump, Xi and Putin, in Shenzhen. The agenda is meant to include nuclear non-proliferation, the war in the Middle East, and trade. The US side does not expect an agreement, but the market will be alert to any signals on tariffs and chip export controls. In the background there is pressure in the debt market: the 10-year yield remains above 5%, and the market is pricing in a 25 bp rate hike in December. Today at 18:00 (Warsaw time), Fed Chair Kevin Warsh will speak. His address concerns the impact of AI on the economy and productivity, so no guidance on rates should be expected. Weakness is also visible in cryptocurrencies, as Bitcoin extends its decline and falls below $65,000.
Chart 1 shows the biggest moves among companies in the Nasdaq index.

Company news
- Nvidia (NVDA.US): The shares are falling ahead of tomorrow’s report. Investors are focused on the uncertainty around the leadership and the effect of export restrictions on sales to China. Nvidia is the weakest of the Magnificent Seven, and the pressure is spreading to the whole sector. Broadcom (AVGO.US) and Intel (INTC.US) are also falling. (down about 2%)
- Nebius (NBIS.US): The company delivered strong third-quarter results (revenue of about $981 million, up about 571% y/y and above consensus), but the market focused on the weaker outlook. (down about 6%)
- Summit Therapeutics (SMMT.US): The US regulator rejected the lung cancer treatment the company is developing with Akeso. This hits the key product on which the valuation was based. (down about 12%)
- Aramark (ARMK.US): Fourth-quarter results disappointed, as adjusted earnings per share and revenue were below expectations. The 2027 guidance was also slightly weaker than consensus. (down about 4%)
- Blackstone Digital Infrastructure Trust (BXDC.US): The trust signed an agreement to buy a 75% stake in two data-center joint ventures with Amazon Web Services. The deal is worth about $5 billion. (up about 4%)
- Centene (CNC.US): Managed-care insurers are gaining after a CMS decision allowing states to delay Medicaid work requirements by six months. This reduces the risk of a drop in the number of insured people. (up about 3%)
- Take-Two Interactive (TTWO.US): Jefferies points to strong pre-orders ahead of Thursday’s launch of Grand Theft Auto VI. (up about 2%)
Technical analysis of US100 (D1)

After bouncing from the November lows around 26,400 points, US100 has come under selling pressure again. The price is still below the 200 EMA (about 28,300 points), and the recent attempt to reclaim it ended in rejection. The 50 EMA has fallen below the 100 EMA around 29,200 points, which worsens the medium-term picture. The RSI around 40 points stays below the neutral level, so sellers have the upper hand. Unless buyers defend the 27,500-point zone, the risk of a retest of the recent lows is rising. A return above the 200 EMA would be the first sign of improvement. Source: xStation5
Calendar for the rest of the session
- 18:00 - Speech by Kevin Warsh (Fed) on the impact of AI on the economy
Daily Summary: PPI Inflation slows down, but EURUSD approaches 1.10
Three Markets to Watch Next Week (13.11.2026)
Morning Wrap: Nvidia sell-off weighs on indices - how many more Huang's affairs must the market price-in? (12.11.2026)
📊Daily Summary: Tech sector drives Wall Street rebound, DAX leads in Europe
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.